Join the club for FREE to access the whole archive and other member benefits.

Investments News

Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal

Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal

FierceBiotech - 26-Jul-2025

Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China

DNA reborn: engineering life from scratch

DNA reborn: engineering life from scratch

BBC - 26-Jun-2025

UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns

Outsee raises 1.8m for AI genomics in drug discovery

Outsee raises 1.8m for AI genomics in drug discovery

Longevity Technology - 25-Jun-2025

Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets

Infinity Bio raises $8m to decode the antibody reactome

Infinity Bio raises $8m to decode the antibody reactome

Longevity Technology - 24-Jun-2025

Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing

Robot surgeons for eyes: ForSight aims to revolutionize cataract surgery

Robot surgeons for eyes: ForSight aims to revolutionize cataract surgery

Forbes - 24-Jun-2025

ForSight’s $125M boost powers eye-surgery robot tested in 300 pig-eye trials, human ops next

Cidara’s new flu drug shows strong protection in adults

Cidara’s new flu drug shows strong protection in adults

BioPharma Dive - 23-Jun-2025

It may be a potential one-time seasonal alternative to vaccines without serious side effects

Parallel Bio raises $21m to replace animal testing with human immune organoids

Parallel Bio raises $21m to replace animal testing with human immune organoids

Longevity Technology - 17-Jun-2025

New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models

Juvena strikes $650m deal with lilly to tackle obesity

Juvena strikes $650m deal with lilly to tackle obesity

Longevity Technology - 11-Jun-2025

AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss

Splicebio raises $135m to advance gene therapy for eye disease

Splicebio raises $135m to advance gene therapy for eye disease

FierceBiotech - 11-Jun-2025

SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech

University spin-out Astratus unveils breakthrough in antibiotic testing

University spin-out Astratus unveils breakthrough in antibiotic testing

University of Reading - 10-Jun-2025

New tech delivers same-day results to improve prescriptions and curb rising antimicrobial resistance

AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition

AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition

Longevity Technology - 05-Jun-2025

Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push

AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost

AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost

Longevity Technology - 30-May-2025

Biotech firm uses AI and robotics to test drugs on real human tissues, not animals

Magnitude Biosciences secures funding to boost AI-powered drug discovery

Magnitude Biosciences secures funding to boost AI-powered drug discovery

BusinessLive - 29-May-2025

Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies

Neuralink raised $600 million, reaching a $9 billion valuation

Neuralink raised $600 million, reaching a $9 billion valuation

Longevity Technology - 28-May-2025

The company is still in early stages but attracting strong investor interest

Maxwell’s AI platform drives revenue growth through health innovation

Maxwell’s AI platform drives revenue growth through health innovation

Live Forever Club - 27-May-2025

India partnerships and FDA progress boost future income

Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials

Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials

FierceBiotech - 27-May-2025

Biotech pivots to drug combo after monotherapy safety and efficacy setbacks

Starfish neuroscience unveils plans for tiny, wireless brain chip

Starfish neuroscience unveils plans for tiny, wireless brain chip

The Verge - 24-May-2025

Valve CEO’s BCI firm builds battery-free chip to interact with multiple brain regions

Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition

Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition

Longevity Technology - 23-May-2025

Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy

Tomorrow.Bio raises 5m to bring cryonics and life-after-death hopes to the U.S.

Tomorrow.Bio raises 5m to bring cryonics and life-after-death hopes to the U.S.

EU-Startups - 22-May-2025

Berlin startup freezes bodies, hoping for future revival

UK biotech Juvenescence secures over $150m to develop therapies

UK biotech Juvenescence secures over $150m to develop therapies

Endpoints News - 21-May-2025

Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases

23andMe’s fall from fame ends in Regeneron takeover

23andMe’s fall from fame ends in Regeneron takeover

BBC - 19-May-2025

Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery

AI startup Somite raises $47m to revolutionize stem cell therapy

AI startup Somite raises $47m to revolutionize stem cell therapy

Longevity Technology - 16-May-2025

Somite AI uses DeltaStem to speed up and scale stem cell engineering

The billionaire blind spot: why longevity science is being overlooked

The billionaire blind spot: why longevity science is being overlooked

NFX - 15-May-2025

Unlocking ageing science could add decades of life—but funding is the missing link

BrightFocus Foundation fuels early research on aging diseases with $13m grants

BrightFocus Foundation fuels early research on aging diseases with $13m grants

Longevity Technology - 13-May-2025

Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma

Rewriting the cell's code: HAYA’s mission to transform genomic medicine

Rewriting the cell's code: HAYA’s mission to transform genomic medicine

Longevity Technology - 12-May-2025

Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states


Display all news